| Address: | 460 Amherst St, Nashua, NH 03063, USA |
|---|---|
| Postal code: | 03063 |
| Phone: | (603) 204-5574 |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Exalenz Biosciences, use the form below and your opinion, advice or comment will appear in this space.
Exalenz Biosciences at 460 Amherst St in Nashua, NH. Exalenz Biosciences. (603) 204-5574.
"Exalenz Biosciences is committed to playing a leading role in reducing the negative health effects and costs associated with H. pylori infection, and the FDA clearance of the BreathID Hp test for use in pediatric patients allows us to expand that role," said Raffi Werner, Chief Executive Officer of Exalenz...
Get store hours, phone number, directions and more for Exalenz Biosciences at 460 Amherst St, Nashua, NH 03063. Address. 460 Amherst St Nashua, NH 03063 US. Phone Number. (603) 204-5574.
Exalenz Biosciences. 460 Amherst Street Nashua, NH 03063. (603) 204-5574. View Contact Info. Do you own this business?
Exalenz Biosciences company data, news, contact details and stock information. Exalenz Bioscience specializes in the diagnosis and monitoring of gastroenterological and liver related diseases, using its proprietary BreathID® Breath Test platform.
Exalenz Biosciences Ltd. About Exalenz Bioscience Exalenz Bioscience develops and markets diagnostic tests and monitoring systems that use the breath to diagnose and help manage gastrointestinal and liver conditions. SOURCE Exalenz Biosciences Ltd.
Exalenz Biosciences announced a collaboration with Conatus Pharmaceuticals. The deal will find Conatus using the BreathID Methacetin Breath Test (MBT) to monitor patients in a Phase IIb clinical trial evaluating emricasan. Emricasan is a treatment for patients experiencing chronic liver disease.
"Exalenz Biosciences is committed to playing a leading role in reducing the negative health effects and costs associated with H. pylori infection, and the FDA clearance of the BreathID Hp test for use in pediatric patients allows us to expand that role," said Raffi Werner, Chief Executive Officer of Exalenz...
by Exalenz Biosciences Ltd. Exalenz Bioscience (TASE: EXEN), a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced receiving U.S. Food and Drug Administration (FDA) marketing...
The BreathID continuous online 13C-MBT (Exalenz Biosciences, Modiin, Israel) is based on the measurement of. CO NFLI CT OF I NTERE ST R.T. Stravitz has received research funding from Exalenz, Biosciences and has otherwise no financial relationships to disclose.